Henningfield, Jack E.
Smith, Tracy T.
Kleykamp, Bethea A.
Fant, Reginald V.
Donny, Eric C.
Funding for this research was provided by:
National Institute on Drug Abuse (U54 DA01659)
Article History
Received: 29 April 2016
Accepted: 15 September 2016
First Online: 21 October 2016
Conflicts of interest
: Through Pinney Associates, Drs. Fant, Henningfield, and Kleykamp have consulted or are presently consulting to GlaxoSmithKline on smoking cessation, NJOY on electronic cigarettes, Reynolds American Vapor Products, and to pharmaceutical companies on substance abuse-related regulatory issues on drug products under development. Henningfield shares interest in a patent for a new nicotine gum for smoking cessation that is under license to Niconovum, which is a smoking cessation product subsidiary of Reynolds American, Inc.Drs. Smith and Donny have no conflicts of interest to report.